Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jean-Pierre Bizzari Insider Profile
4 Followers
Jean-Pierre Bizzari, Director at Halozyme, holds 66.81K shares in Halozyme (Ticker: HALO), holds ― shares in Pieris Pharmaceuticals (Ticker: PIRS), holds ― shares in Aprea Therapeutics (Ticker: APRE).
Jean-Pierre Bizzari has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jean-Pierre Bizzari holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jean-Pierre Bizzari
Jean-Pierre Bizzari's Trading History
Halozyme
May 09, 2023
Director
Uninformative Buy
―
$2.53M
Pieris Pharmaceuticals
―
Director
―
―
Aprea Therapeutics
―
Director
―
―
Celator Pharmaceuticals
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Jean-Pierre Bizzari's performance on stock
You May Also Like
Jean-Pierre Bizzari insider profile FAQ
What is the percentage of profitable transactions made by Jean-Pierre Bizzari?
The percentage of profitable transactions made by Jean-Pierre Bizzari is ―.
What is the average return per transaction made by Jean-Pierre Bizzari?
The average return per transaction made by Jean-Pierre Bizzari is ―.
What stocks does Jean-Pierre Bizzari hold?
Jean-Pierre Bizzari holds: HALO, PIRS, APRE, CLPM stocks.
What was Jean-Pierre Bizzari’s latest transaction?
Jean-Pierre Bizzari latest transaction was an Uninformative Buy of ―.
What was Jean-Pierre Bizzari's most profitable transaction?
Jean-Pierre Bizzari’s most profitable transaction was an Informative Sell of HALO stock on August 25, 2021. The return on the trade was -3.10%.
What is Jean-Pierre Bizzari's role in Halozyme?
Jean-Pierre Bizzari's role in Halozyme is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.